Clinicopathological study of fulminant hepatitis: coinfection with hepatitis B virus and delta agent.
D000208:Acute Disease; D000293:Adolescent; D000914:Antibodies, Viral / Q000032:analysis; D005260:Female; D006509:Hepatitis B / Q000150:complications* / Q000276:immunology / Q000473:pathology; D006510:Hepatitis B Antibodies / Q000032:analysis; D006514:Hepatitis B Surface Antigens / Q000032:analysis; D003699:Hepatitis D / Q000150:complications* / Q000276:immunology / Q000473:pathology; D003698:Hepatitis Delta Virus / Q000276:immunology; D006525:Hepatitis, Viral, Human / Q000276:immunology / Q000473:pathology*; D006801:Humans; D007158:Immunologic Techniques; D008099:Liver / Q000473:pathology; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious; D019966:Substance-Related Disorders / Q000150:complications
D000914:Antibodies, Viral; D006510:Hepatitis B Antibodies; D006514:Hepatitis B Surface Antigens